Brief: Enanta Pharmaceuticals Q3 Revenue USD 17.971 Million Vs. IBES Estimate USD 17.2 Million
05/08/2024 21:01
Aug 05 (Reuters) - Enanta Pharmaceuticals Q3 pretax profit USD -23.053 million. * Q3 net income USD -22.658 million vs. IBES estimate USD -31.8 million * Q3 operating income USD -24.185 million * Q3 operating expenses USD 42.156 million
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates